Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease

被引:10
作者
Zhou, Zihang [1 ]
Yan, Yalong [1 ]
Gu, Heng [1 ]
Sun, Ruiao [1 ]
Liao, Zihan [1 ]
Xue, Ke [1 ]
Tang, Chuanxi [1 ]
机构
[1] Xuzhou Med Univ, Dept Neurobiol, Xuzhou Key Lab Neurobiol, Xuzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
dopamine; dopamine receptor; dopamine transporter; executive dysfunction; neural network; neural oscillation; prefrontal cortex; synaptic plasticity; MILD COGNITIVE IMPAIRMENT; DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; WORKING-MEMORY; DIAGNOSTIC-CRITERIA; NEURAL MECHANISMS; CORTICAL DOPAMINE; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; BASAL GANGLIA;
D O I
10.4103/1673-5374.389631
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease can affect not only motor functions but also cognitive abilities, leading to cognitive impairment. One common issue in Parkinson's disease with cognitive dysfunction is the difficulty in executive functioning. Executive functions help us plan, organize, and control our actions based on our goals. The brain area responsible for executive functions is called the prefrontal cortex. It acts as the command center for the brain, especially when it comes to regulating executive functions. The role of the prefrontal cortex in cognitive processes is influenced by a chemical messenger called dopamine. However, little is known about how dopamine affects the cognitive functions of patients with Parkinson's disease. In this article, the authors review the latest research on this topic. They start by looking at how the dopaminergic system, is altered in Parkinson's disease with executive dysfunction. Then, they explore how these changes in dopamine impact the synaptic structure, electrical activity, and connection components of the prefrontal cortex. The authors also summarize the relationship between Parkinson's disease and dopamine-related cognitive issues. This information may offer valuable insights and directions for further research and improvement in the clinical treatment of cognitive impairment in Parkinson's disease.
引用
收藏
页码:1759 / 1767
页数:9
相关论文
共 155 条
  • [1] The rate of cognitive decline in Parkinson disease
    Aarsland, D
    Andersen, K
    Larsen, JP
    Perry, R
    Wentzel-Larsen, T
    Lolk, A
    Kragh-Sorensen, P
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (12) : 1906 - 1911
  • [2] Mild cognitive impairment in Parkinson disease A multicenter pooled analysis
    Aarsland, D.
    Bronnick, K.
    Williams-Gray, C.
    Weintraub, D.
    Marder, K.
    Kulisevsky, J.
    Burn, D.
    Barone, P.
    Pagonabarraga, J.
    Allcock, L.
    Santangelo, G.
    Foltynie, T.
    Janvin, C.
    Larsen, J. P.
    Barker, R. A.
    Emre, M.
    [J]. NEUROLOGY, 2010, 75 (12) : 1062 - 1069
  • [3] Prefrontal dopamine D1 receptors and working memory in schizophrenia
    Abi-Dargham, A
    Mawlawi, O
    Lombardo, I
    Gil, R
    Martinez, D
    Huang, YY
    Hwang, DR
    Keilp, J
    Kochan, L
    Van Heertum, R
    Gorman, JM
    Laruelle, M
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (09) : 3708 - 3719
  • [4] An Open-Source Cognitive Test Battery to Assess Human Attention and Memory
    Adolphe, Maxime
    Sawayama, Masataka
    Maurel, Denis
    Delmas, Alexandra
    Oudeyer, Pierre-Yves
    Sauzeon, Helene
    [J]. FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [5] Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats
    Albeely, Abdalla M.
    Nolan, Caitlin J.
    Rasmussen, Duncan J.
    Bailey, Craig D. C.
    Perreault, Melissa L.
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2469 - 2480
  • [6] Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson's Disease: A Basic and Clinical Approach
    Alberto Gonzalez-Usigli, Hector
    Gabriel Ortiz, Genaro
    Charles-Nino, Claudia
    Alberto Mireles-Ramirez, Mario
    Paul Pacheco-Moises, Fermin
    Miriam de Guadalupe Torres-Mendoza, Blanca
    de Jesus Hernandez-Cruz, Jose
    Lucero del Carmen Delgado-Lara, Daniela
    Javier Ramirez-Jirano, Luis
    [J]. BRAIN SCIENCES, 2023, 13 (03)
  • [7] Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
    Alster, Piotr
    Madetko, Natalia
    Koziorowski, Dariusz
    Friedman, Andrzej
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [8] Cell-Type Specificity of Callosally Evoked Excitation and Feedforward Inhibition in the Prefrontal Cortex
    Anastasiades, Paul G.
    Marlin, Joseph J.
    Carter, Adam G.
    [J]. CELL REPORTS, 2018, 22 (03): : 679 - 692
  • [9] Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience
    Appleby, Brian S.
    Duggan, Patrick S.
    Regenberg, Alan
    Rabins, Peter V.
    [J]. MOVEMENT DISORDERS, 2007, 22 (12) : 1722 - 1728
  • [10] DOPAMINE D-1 RECEPTOR MECHANISMS IN THE COGNITIVE PERFORMANCE OF YOUNG-ADULT AND AGED MONKEYS
    ARNSTEN, AFT
    CAI, JX
    MURPHY, BL
    GOLDMANRAKIC, PS
    [J]. PSYCHOPHARMACOLOGY, 1994, 116 (02) : 143 - 151